Event
Axxam at Drug Discovery USA 2026
Date: 16-17 June 2026
Location: Boston, MA, USA
- Sponsored Talk: TDP-43 Therapeutics: Assays for Novel Modality Discovery in ALS/FTD
Sarah Bernard
BD Senior Director – North America
Daniela Crespi
Scientific Research Expert
Advancing Drug Discovery for Neurodegenerative Diseases
Axxam is pleased to participate in Drug Discovery USA 2026 as a Conference Partner. The event brings together scientists and industry leaders focused on the latest advances in drug discovery, screening technologies, translational models, and therapeutic innovation.
Join us to discuss how Axxam supports drug discovery programs through integrated assay development, high-throughput screening, advanced cellular models, and translational biology platforms.
Sponsored Presentation
TDP-43 Therapeutics: Assays for Novel Modality Discovery in ALS/FTD
- Date: June 16, 2026
- Time: 9:45 AM – 10:15 AM
- Where: The Auditorium – Track 1
- Format: Sponsored Presentation (30 minutes)
TDP-43 dysfunction is a hallmark of both amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), making it a highly relevant target for therapeutic intervention. During this presentation, Axxam will highlight assay platforms and discovery approaches designed to support the identification and characterization of novel therapeutic modalities targeting TDP-43 biology.
Attendees will learn how disease-relevant screening strategies and translational models can accelerate the discovery of innovative therapies for neurodegenerative disorders.
Why meet with Axxam?
- Advanced Models for Complex Biology
Disease-relevant cellular systems, iPSC-derived models, high-content imaging, and phenotypic screening approaches. - Integrated Discovery Support
Connected technologies spanning assay development, screening, hit validation, and compound characterization. - Neurodegeneration Expertise
Innovative platforms supporting target validation and therapeutic discovery in ALS, FTD, Parkinson’s disease, Alzheimer’s disease, and related disorders. - Flexible Collaboration Models
Stand-alone services, dedicated FTE support, or fully integrated discovery programs tailored to project needs.
Schedule a Meeting
If you are attending Drug Discovery USA 2026, we invite you to connect with our team to discuss your drug discovery challenges and explore potential collaboration opportunities.